Breakthrough CRISPR Therapy Slashes Bad Cholesterol by Over 50% With a Single Infusion
In a groundbreaking advancement for cardiovascular medicine, a single-dose gene-editing therapy has demonstrated the remarkable ability to significantly lower dangerous cholesterol and triglyceride levels for at least a full year. The landmark Phase 1 trial...